(Q37811593)

23 August 2017

1 reference

title

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence (English)

1 reference

23 August 2017

Masson EA

1

1 reference

23 August 2017

Boulton AJ

series ordinal

2

1 reference

23 August 2017

language of work or name

1 reference

1 February 1990

1 reference

23 August 2017

1 reference

23 August 2017

39

1 reference

23 August 2017

190-202

1 reference

23 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199039020-00003

23 August 2017

0 references

cites work

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil

1 reference

12 December 2020

Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

1 reference

12 December 2020

Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy

1 reference

12 December 2020

Sural nerve oxygen tension in diabetes

1 reference

12 December 2020

An improved automated method for the measurement of thermal thresholds. 1. Normal subjects

1 reference

12 December 2020

Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study

1 reference

12 December 2020

Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals

1 reference

12 December 2020

Improvement in nerve conduction following treatment in newly diagnosed diabetics

1 reference

12 December 2020

Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat

1 reference

12 December 2020

The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study

1 reference

12 December 2020

Small vessel disease in progressive diabetic neuropathy associated with good metabolic control

1 reference

12 December 2020

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

12 December 2020

Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosaemia

1 reference

12 December 2020

The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats

1 reference

12 December 2020

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry

1 reference

12 December 2020

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

1 reference

12 December 2020

Action of Sorbinil in Diabetic Peripheral Nerve: Relationship of Polyol (Sorbitol) Pathway Inhibition to a myo-Inositol-mediated Defect in Sodium-Potassium ATPase Activity

1 reference

12 December 2020

Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

1 reference

12 December 2020

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

1 reference

12 December 2020

Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy

1 reference

12 December 2020

Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy.

1 reference

12 December 2020

Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil

1 reference

12 December 2020

Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?

1 reference

12 December 2020

Diabetic neuropathy in the upper limb and the effect of twelve months sorbinil treatment

1 reference

12 December 2020

A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy

1 reference

12 December 2020

Effect of myo-inositol on peripheral-nerve function in diabetes

1 reference

12 December 2020

Recent advances in the pathogenesis of diabetic neuropathy.

1 reference

12 December 2020

The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia

1 reference

12 December 2020

Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report

1 reference

12 December 2020

Diabetic neuropathies and pain

1 reference

12 December 2020

Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects

1 reference

12 December 2020

Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial

1 reference

12 December 2020

Clinical experience with sorbinil--an aldose reductase inhibitor

1 reference

12 December 2020

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

1 reference

12 December 2020

Variability in vibration perception threshold among sites: a potential source of error in biothesiometry

1 reference

12 December 2020

Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.

1 reference

12 December 2020

Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes

1 reference

12 December 2020

Report and recommendations of the San Antonio conference on diabetic neuropathy. Consensus statement

1 reference

12 December 2020

Clinical trial of an aldose reductase inhibitor in diabetic neuropathy

1 reference

12 December 2020

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

12 December 2020

Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function

1 reference

12 December 2020

Reversible nervous abnormalities in juvenile diabetics with recently diagnosed diabetes

1 reference

12 December 2020

Diagnostic, pathogenetic, and therapeutic aspects of diabetic neuropathy

1 reference

12 December 2020

Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients

1 reference

12 December 2020

Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects.

1 reference

12 December 2020

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

12 December 2020

Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

Is resistance to ischaemic conduction failure induced by hypoxia?

1 reference

12 December 2020

The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients

1 reference

12 December 2020

Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy.

1 reference

12 December 2020

Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.

1 reference

12 December 2020

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

1 reference

12 December 2020

The natural history of acute painful neuropathy in diabetes mellitus

1 reference

12 December 2020

10.2165/00003495-199039020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference